Stocksigma LogoStocksigma Logo

USFDA Concludes Inspection at Cohance Lifesciences Formulation Facility with Four Observations

The USFDA completed an inspection of Cohance Lifesciences Limited's formulation (FDF) plant located at Shamshabad, Telangana, conducted from 27th Aug'26 to

USFDA Concludes Inspection at Cohance Lifesciences Formulation Facility with Four Observations

Cohance Lifesciences Ltd 路 Others (Uncategorized) 路 05 Sept 2026, 5:59 am

USFDA Concludes Inspection at Cohance Lifesciences Formulation Facility with Four Observations The USFDA completed an inspection of Cohance Lifesciences Limited's formulation (FDF) plant located at Shamshabad, Telangana, conducted from 27th Aug'26 to 4th Sep'26. The regulatory audit concluded with the issuance of a Form FDA 483 containing four observations. The company confirmed it has initiated appropriate corrective and preventive actions (CAPA) and will submit its formal response to the regulatory agency within the stipulated timeline.

Original exchange filing (PDF)

More announcements from Cohance Lifesciences Ltd

All Cohance Lifesciences Ltd announcements